Uncovering unique roles of LPA receptors in the tumor microenvironment
- PMID: 26005700
- PMCID: PMC4438998
- DOI: 10.14800/rci.440
Uncovering unique roles of LPA receptors in the tumor microenvironment
Abstract
The role of the lysophospholipase D autotaxin (ATX) and lysophosphatidic acid (LPA) in cancer is emerging and represents two key players in regulating cancer progression. In this brief review, we will discuss some of our recent findings, which highlight a central role that LPA and its receptor plays in orchestrating melanoma-stroma interactions in the establishment of lung metastases. In particular, we evaluated not only the function of LPA receptors on tumor cells but also their role on host tissues and how they can influence melanoma growth and metastasis. Using the syngeneic B16F10 murine melanoma model, we made three key observations. First, our in vitro findings demonstrate that LPA receptors, specifically LPA2 and LPA5 expressed in B16F10 cells appear to have opposing roles in cell invasion; the former seems to be responsible for the high basal invasion rate of B16F10 cells while the latter is anti-invasive upon exogenous LPA stimulation. Second, we observed a profound reduction in the incidence of pulmonary melanoma metastasis in LPA1- and LPA5-knockout (KO) mice, respectively, when compared to wild-type (WT) mice. Third, no differences in terms of subcutaneous tumor growth between LPA1KO, LPA5KO and WT mice were observed. These findings suggest that LPA receptors exert different functions in melanoma cells versus host tissues in terms of invasion and metastasis.
Keywords: Lysophosphatidic acid receptor; autotoxin; invasion; melanoma; metastasis; tumor microenvironment.
Conflict of interest statement
The authors declare no competing financial interests.
Similar articles
-
Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.Mol Cancer Res. 2015 Jan;13(1):174-85. doi: 10.1158/1541-7786.MCR-14-0263. Epub 2014 Aug 26. Mol Cancer Res. 2015. PMID: 25158955 Free PMC article.
-
Regulation of tumor cell - Microenvironment interaction by the autotaxin-lysophosphatidic acid receptor axis.Adv Biol Regul. 2019 Jan;71:183-193. doi: 10.1016/j.jbior.2018.09.008. Epub 2018 Sep 16. Adv Biol Regul. 2019. PMID: 30243984 Free PMC article. Review.
-
Prometastatic Effect of ATX Derived from Alveolar Type II Pneumocytes and B16-F10 Melanoma Cells.Cancers (Basel). 2022 Mar 21;14(6):1586. doi: 10.3390/cancers14061586. Cancers (Basel). 2022. PMID: 35326737 Free PMC article.
-
Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA5 in melanoma cells treated with anticancer drugs.Biochem Biophys Res Commun. 2019 Sep 17;517(2):359-363. doi: 10.1016/j.bbrc.2019.07.092. Epub 2019 Jul 27. Biochem Biophys Res Commun. 2019. PMID: 31362892
-
The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme.Lipids Health Dis. 2015 Jun 18;14:56. doi: 10.1186/s12944-015-0059-5. Lipids Health Dis. 2015. PMID: 26084470 Free PMC article. Review.
Cited by
-
Lysophosphatidic acid induces tumor necrosis factor-alpha to regulate a pro-inflammatory cytokine network in ovarian cancer.FASEB J. 2020 Oct;34(10):13935-13948. doi: 10.1096/fj.202001136R. Epub 2020 Aug 26. FASEB J. 2020. PMID: 32851734 Free PMC article.
-
Role of autotaxin in cancer stem cells.Cancer Metastasis Rev. 2018 Sep;37(2-3):509-518. doi: 10.1007/s10555-018-9745-x. Cancer Metastasis Rev. 2018. PMID: 29926310 Free PMC article. Review.
-
Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.Cancers (Basel). 2018 Mar 15;10(3):73. doi: 10.3390/cancers10030073. Cancers (Basel). 2018. PMID: 29543710 Free PMC article. Review.
-
Exosomes bind to autotaxin and act as a physiological delivery mechanism to stimulate LPA receptor signalling in cells.J Cell Sci. 2016 Oct 15;129(20):3948-3957. doi: 10.1242/jcs.184424. Epub 2016 Aug 24. J Cell Sci. 2016. PMID: 27557622 Free PMC article.
-
Endogenous Anti-Cancer Candidates in GPCR, ER Stress, and EMT.Biomedicines. 2020 Oct 9;8(10):402. doi: 10.3390/biomedicines8100402. Biomedicines. 2020. PMID: 33050301 Free PMC article. Review.
References
-
- Choi JW, Herr DR, Noguchi K, Yung YC, Lee C-W, Mutoh T, et al. LPA Receptors: Subtypes and Biological Actions. Annu Rev Pharmacol Toxicol. 2010;50:157–186. - PubMed
-
- Euer N, Schwirzke M, Evtimova V, Burtscher H, Jarsch M, Tarin D, et al. Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines. Anticancer Res. 2002;22:733–740. - PubMed
-
- So J, Wang FQ, Navari J, Schreher J, Fishman DA. LPA-induced epithelial ovarian cancer (EOC) in vitro invasion and migration are mediated by VEGF receptor-2 (VEGF-R2) Gynecol Oncol. 2005;97:870–878. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous